Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Research Square
|
April 8, 2024
Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
NPJ Systems Biology and Applications
|
August 14, 2024
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
ACS Nano
|
November 6, 2013
Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response
Jennifer Pascal, Carlee E Ashley, Zhihui Wang, et al.
Pharmaceutical Research
|
March 16, 2022
Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer
Prashant Dogra, Javier Ruiz Ramírez, Joseph D Butner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model
Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, et al.
ACS Pharmacology & Translational Science
|
February 22, 2021
Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model
Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Cell Death & Disease
|
May 21, 2022
Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
Molecular Cancer
|
August 2, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Prashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Prashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Research Square
|
April 8, 2024
Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
NPJ Systems Biology and Applications
|
August 14, 2024
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
ACS Nano
|
November 6, 2013
Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response
Jennifer Pascal, Carlee E Ashley, Zhihui Wang, et al.
Pharmaceutical Research
|
March 16, 2022
Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer
Prashant Dogra, Javier Ruiz Ramírez, Joseph D Butner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 11, 2020
Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model
Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, et al.
ACS Pharmacology & Translational Science
|
February 22, 2021
Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model
Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, et al.
Science Advances
|
May 20, 2020
Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
Joseph D Butner, Dalia Elganainy, Charles X Wang, et al.
Cell Death & Disease
|
May 21, 2022
Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study
Joseph D Butner, Prashant Dogra, Caroline Chung, et al.
Molecular Cancer
|
August 2, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Prashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2024
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Prashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, et al.
Page
of 4